Literature DB >> 29313312

Influence of Single-Dose Antibiotic Prophylaxis for Early-Onset Pneumonia in High-Risk Intubated Patients.

Timothy D Lewis1,2, Kelly A Dehne1,2, Kathryn Morbitzer1,2, Denise H Rhoney2, Casey Olm-Shipman3, J Dedrick Jordan4.   

Abstract

BACKGROUND: Early-onset pneumonia (EOP) after endotracheal intubation is common among critically ill patients with a neurologic injury and is associated with worse clinical outcomes.
METHODS: This retrospective cohort study observed outcomes pre- and post-implementation of an EOP prophylaxis protocol which involved the administration of a single dose of ceftriaxone 2 g around the time of intubation. The study included patients ≥ 18 years who were admitted to the University of North Carolina Medical Center (UNCMC) neuroscience intensive care unit (NSICU) between April 1, 2014, and October 26, 2016, and intubated for ≥ 72 h.
RESULTS: Among the 172 patients included, use of an EOP prophylaxis protocol resulted in a significant reduction in the rate of microbiologically confirmed EOP compared to those without prophylaxis (7.4 vs 19.8%, p = 0.026). However, EOP prophylaxis did not decrease the combined incidence of microbiologically confirmed or clinically suspected EOP (32.2 vs 37.4%, p = 0.523). No difference in the rate of late-onset pneumonia (34.6 vs 26.4%, p = 0.25) or virulent organism growth (19.8 vs 14.3%, p = 0.416) was observed. No difference was observed in the duration of intubation, duration of intensive care unit (ICU) stay, duration of hospitalization, or ICU antibiotic days within 30 days of intubation. In hospital mortality was found to be higher in those who received EOP prophylaxis compared to those who did not receive prophylaxis (45.7 vs 29.7%, p = 0.04).
CONCLUSIONS: The administration of a single antibiotic dose following intubation may reduce the incidence of microbiologically confirmed EOP in patients with neurologic injury who are intubated ≥ 72 h. A prophylaxis strategy does not appear to increase the rate of virulent organism growth or the rate of late-onset pneumonia. However, this practice is not associated with a decrease in days of antibiotic use in the ICU or any clinical outcomes benefit.

Entities:  

Keywords:  Ceftriaxone; Infection; Intubation; Mechanical ventilation; Pneumonia; Prophylaxis

Mesh:

Substances:

Year:  2018        PMID: 29313312     DOI: 10.1007/s12028-017-0490-8

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  11 in total

1.  Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia.

Authors:  S Ewig; A Torres; M El-Ebiary; N Fábregas; C Hernández; J González; J M Nicolás; L Soto
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

2.  Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.

Authors:  Michael Klompas; Richard Branson; Eric C Eichenwald; Linda R Greene; Michael D Howell; Grace Lee; Shelley S Magill; Lisa L Maragakis; Gregory P Priebe; Kathleen Speck; Deborah S Yokoe; Sean M Berenholtz
Journal:  Infect Control Hosp Epidemiol       Date:  2014-09       Impact factor: 3.254

3.  Comparative in vitro activity of ceftriaxone against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

4.  Antibiotic Therapy in Comatose Mechanically Ventilated Patients Following Aspiration: Differentiating Pneumonia From Pneumonitis.

Authors:  Jean Baptiste Lascarrou; Floriane Lissonde; Aurélie Le Thuaut; Konstantinos Bachoumas; Gwenhael Colin; Matthieu Henry Lagarrigue; Isabelle Vinatier; Maud Fiancette; Jean Claude Lacherade; Aihem Yehia; Aurélie Joret; Christine Lebert; Sandra Bourdon; Laurent Martin Lefèvre; Jean Reignier
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

5.  Retrospective analysis of the risk factors and pathogens associated with early-onset ventilator-associated pneumonia in surgical-ICU head-trauma patients.

Authors:  Didier Lepelletier; Antoine Roquilly; Dominique Demeure dit latte; Pierre Joachim Mahe; Olivier Loutrel; Philippe Champin; Stéphane Corvec; Edouard Naux; Michel Pinaud; Corinne Lejus; Karim Asehnoune
Journal:  J Neurosurg Anesthesiol       Date:  2010-01       Impact factor: 3.956

6.  Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma.

Authors:  J M Sirvent; A Torres; M El-Ebiary; P Castro; J de Batlle; A Bonet
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

7.  Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome.

Authors:  Pierre Esnault; Cédric Nguyen; Julien Bordes; Erwan D'Aranda; Ambroise Montcriol; Claire Contargyris; Jean Cotte; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Henry Boret; Eric Meaudre
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

8.  Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study.

Authors:  A Acquarolo; T Urli; G Perone; C Giannotti; A Candiani; N Latronico
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

9.  Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilated.

Authors:  Jordi Vallés; Raquel Peredo; Maria Jose Burgueño; A Patrícia Rodrigues de Freitas; Susana Millán; Mateu Espasa; Ignacio Martín-Loeches; Ricard Ferrer; David Suarez; Antonio Artigas
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Early onset pneumonia: risk factors and consequences in head trauma patients.

Authors:  Régis Bronchard; Pierre Albaladejo; Gilles Brezac; Arnaud Geffroy; Pierre-François Seince; William Morris; Catherine Branger; Jean Marty
Journal:  Anesthesiology       Date:  2004-02       Impact factor: 7.892

View more
  1 in total

Review 1.  [Update of the recommendations of the Pneumonia Zero project].

Authors:  S Arias-Rivera; R Jam-Gatell; X Nuvials-Casals; M Vázquez-Calatayud
Journal:  Enferm Intensiva       Date:  2022-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.